相关实验视频

Updated: Jul 10, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Pleural mesothelioma:在血液和 Pleural 生物标志物方面的进展

Claudio Sorino¹, Michele Mondoni², Giampietro Marchetti³

¹Division of Pulmonology, Sant'Anna Hospital of Como, University of Insubria, 21100 Varese, Italy.

Journal of clinical medicine

|November 25, 2023

概括

识别肺部间皮瘤 (PM) 的可靠生物标志物对于诊断和预后至关重要. 虽然血清中素显示有前途,但需要进一步的研究,以改善早期检测和治疗结果,这种石棉相关的癌症.

科学领域:

在瘤学瘤学.
生物标志物发现发现
与石棉相关的疾病

背景情况:

排骨间皮瘤 (PM) 是一种与石暴露相关的侵袭性癌症,预后不佳.
目前PM的诊断和预后工具有限,缺乏治疗反应或长期结果的验证预测因素.
胸腔液和血清中的最小侵入性生物标志物正在研究以早期诊断和预后评估.

研究的目的:

审查目前的小入侵性生物标志物,以检测肺部间皮瘤 (PM).
评估多液和血清中各种生物标志物的诊断和预后能力.
评估生物标记面板和蛋白质组学在改善间皮瘤患者管理方面的潜力.

主要方法:

审查研究的研究,调查肺部液体和血清生物标志物PM.
对美索林,纤维素-3,氨酸,微RNA,CYFRA-21.1和骨质的分析.
作为FDA批准的生物标志物的可溶性美索相关 (SMRP) 的评估.
考虑生物标记面板和蛋白质组学技术.

主要成果:

Pleural effusion 中的 mesothelin 具有良好的特异性,但敏感性较低,特别是对于非表皮质 PM.
其他胸腔液标记物,如纤维素-3和microRNAs提供预后信息.
血清生物标志物,包括美索林,骨质素和纤维素-3,被广泛研究.
可溶性美索相关 (SMRP) 是FDA批准的,有助于诊断,预后和治疗反应评估表皮质PM.
生物标志物面板和蛋白质组学显示出提高临床性能的潜力.

结论:

目前的生物标志物,包括SMRP,为PM提供了有价值的诊断和预后信息,特别是表皮类型.
虽然有希望,但现有的生物标志物和面板缺乏通过早期检测改善治疗结果的明确证据.
对新型生物标志物和综合方法进行进一步的研究是必要的,以更好地管理间皮瘤患者.

关键词:

生物标志物生物标志物纤维素-3-蛋白-3-蛋白是指纤维素-3的组成部分.梅索他林是其中一种.半质瘤 (Mesothelioma) 是一种中质瘤.胸腔溢出胸腔溢出胸腔溢出胸腔溢出

更多相关视频

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

相关概念视频

Pleural Disorders: Types and Brief Description

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

Pleural Effusion I: Introduction

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...